To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Arms Length Body Publication (Published)
NICE

Jul. 30 2025

Source Page: Vanzacaftor-tezacaftor-deutivacaftor for treating cystic fibrosis with 1 or more F508del mutations in the CFTR gene in people 6 years and over
Publication Type: Summary PDF
Document: Download (PDF) (webpage)
Arms Length Body Publication (Published)
NICE

Jul. 30 2025

Source Page: Vanzacaftor-tezacaftor-deutivacaftor for treating cystic fibrosis with 1 or more F508del mutations in the CFTR gene in people 6 years and over
Publication Type: Summary PDF
Document: Download guidance (PDF) (webpage)
Arms Length Body Publication (Policy or strategy)
NHS England

Jul. 30 2025

Source Page: Emicizumab for prophylaxis of bleeding episodes in people with moderate haemophilia A without inhibitors
Document: Clinical commissioning policy: Emicizumab for prophylaxis of bleeding episodes in people with moderate haemophilia A without inhibitors (all ages) (PDF)
Arms Length Body Publication (Policy or strategy)
NHS England

Jul. 30 2025

Source Page: Tocilizumab for neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease refractory or intolerant to previous lines of therapy
Document: Clinical commissioning policy: Tocilizumab for neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) refractory or intolerant to previous lines of therapy (Adults) (PDF)
Arms Length Body Publication (Policy or strategy)
NHS England

Jul. 30 2025

Source Page: Icatibant for treatment of moderate to severe acute swellings due to bradykinin-mediated angioedema with normal C1 inhibitor
Document: Clinical commissioning policy: Icatibant for treatment of moderate to severe acute swellings due to bradykinin-mediated angioedema with normal C1 inhibitor (PDF)
Arms Length Body Publication (Letter)
NHS England

Jul. 30 2025

Source Page: Thank you letter to NHS staff from Secretary of State and Jim Mackey
Document: Thank you letter to NHS staff from Secretary of State and Jim Mackey (webpage)
Arms Length Body Publication (Published)
NICE

Jul. 24 2025

Source Page: Digital front door technologies to gather service user information for NHS Talking Therapies for anxiety and depression assessments: early value assessment
Publication Type: Expected publication
Document: Consultation comments and responses (PDF 355 KB) (webpage)
Arms Length Body Publication (Published)
NICE

Jul. 24 2025

Source Page: Digital front door technologies to gather service user information for NHS Talking Therapies for anxiety and depression assessments: early value assessment
Publication Type: Expected publication
Document: Equality impact assessment (downloadable version) (PDF 114 KB) (webpage)
Arms Length Body Publication (Published)
NICE

Jul. 24 2025

Source Page: Digital front door technologies to gather service user information for NHS Talking Therapies for anxiety and depression assessments: early value assessment
Publication Type: Stakeholder list updated
Document: Stakeholder list (PDF 72 KB) (webpage)
Arms Length Body Publication (Published)
NICE

Jul. 24 2025

Source Page: Digital front door technologies to gather service user information for NHS Talking Therapies for anxiety and depression assessments: early value assessment
Publication Type: Declaration of interests
Document: Register of interests (PDF 176 KB) (webpage)